TipRanks
Jagsonpal Pharmaceuticals Ltd. (IN:JAGSNPHARM)
:JAGSNPHARM
India Market
Want to see IN:JAGSNPHARM full AI Analyst Report?

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting Jagsonpal Pharmaceuticals Ltd. is a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 20-Day exponential moving average is 232.55, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-Day exponential moving average is 230.36, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Sell.

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Pivot Points

Oct 12, 2026, 04:39 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
224.28
227.07
228.83
231.62
233.38
236.17
237.93
Fibonacci
227.07
228.80
229.88
231.62
233.35
234.43
236.17
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Moving Averages

Oct 12, 2026, 04:39 PM
Period
Simple
Exponential
MA5
230.96Sell
230.41Sell
MA10
234.16Sell
231.94Sell
MA20
231.99Sell
232.55Sell
MA50
232.23Sell
230.36Sell
MA100
223.40Buy
223.59Buy
MA200
203.42Buy
210.55Buy
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 10-Day exponential moving average is 231.94, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Sell.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-Day exponential moving average is 223.59, while Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) share price is ₹193.5, making it a Buy.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 50-day simple moving average is 232.23, creating a Sell signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 100-day simple moving average is 223.40, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) stock price is ₹193.5 and Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) 200-day simple moving average is 203.42, creating a Buy signal.

Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) Technical Indicators

Oct 12, 2026, 04:39 PM
Name
Value
Implied Action
RSI (14)
42.15
Neutral
STOCH (9,6)
21.50
Neutral
STOCHRSI (14)
27.54
Neutral
MACD (12,26)
-0.26
Buy
ADX (14)
18.75
Buy
Williams %R
-89.57
Buy
CCI (14)
-79.72
Neutral
ATR (14)
9.02
-
Ultimate Oscillator
34.83
Neutral
ROC
-1.12
Sell
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Relative Strength Index (RSI) is 42.15, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Trend Strength Indicator (ADX) is 18.75, creating a Buy signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Commodity Channel Index (CCI) is -79.72, creating a Neutral signal.
Jagsonpal Pharmaceuticals Ltd.’s (JAGSNPHARM) Price Rate of Change (ROC) is -1.12, creating a Sell signal.

FAQ

Is JAGSNPHARM a Buy, Hold, or Sell?
Based on JAGSNPHARM’s technical indicators, JAGSNPHARM is a Sell.
    What is JAGSNPHARM’s RSI (14)?
    JAGSNPHARM’s RSI (14) is 42.15, which suggests JAGSNPHARM is a Neutral.
      What is JAGSNPHARM’s MACD?
      JAGSNPHARM’s MACD is -0.26, which suggests JAGSNPHARM is a Buy.
        What is JAGSNPHARM’s 5-day moving average?
        JAGSNPHARM’s 5-day moving average is 230.96, which suggests JAGSNPHARM is a Sell.
          What is JAGSNPHARM’s 20-day moving average?
          JAGSNPHARM 20-day moving average is 231.99, which suggests JAGSNPHARM is a Sell.
            What is JAGSNPHARM’s 50-day moving average?
            JAGSNPHARM’s 50-day moving average is 232.23, which suggests JAGSNPHARM is a Sell.
              What is JAGSNPHARM’s 200-day moving average?
              JAGSNPHARM’s 200-day moving average is 203.42, which suggests JAGSNPHARM is a Buy.
                What is JAGSNPHARM’s Williams % R (14)?
                JAGSNPHARM’s Williams % R (14) is -89.57, which suggests JAGSNPHARM is a Buy.
                  What is JAGSNPHARM’s CCI (14)?
                  JAGSNPHARM’s CCI (14) is -79.72, which suggests JAGSNPHARM is a Neutral.
                    What is the share price of Jagsonpal Pharmaceuticals Ltd.?